ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Fabrazyme (agalsidase beta) Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-33H10288
Home | Market Reports | Health| Pharmacy
Global and United States Fabrazyme agalsidase beta Market Report Forecast 2022 2028
BUY CHAPTERS

Global Fabrazyme (agalsidase beta) Market Insights, Forecast to 2030

Code: QYRE-Auto-33H10288
Report
December 2024
Pages:75
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Genzyme Corporation

Fabrazyme (agalsidase beta) Market

Fabrazyme® (agalsidase beta) is used to treat patients with Fabry disease. Fabrazyme lowers the amount of a substance called globotriaosylceramide (GL-3), which builds up in cells lining the blood vessels of the kidney and certain other cells.
The global Fabrazyme (agalsidase beta) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Fabrazyme (agalsidase beta) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Fabrazyme (agalsidase beta) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Fabrazyme (agalsidase beta) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Fabrazyme (agalsidase beta) include Genzyme Corporation. etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Fabrazyme (agalsidase beta), sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Fabrazyme (agalsidase beta), also provides the sales of main regions and countries. Highlights of the upcoming market potential for Fabrazyme (agalsidase beta), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Fabrazyme (agalsidase beta) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Fabrazyme (agalsidase beta) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Fabrazyme (agalsidase beta) sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Fabrazyme (agalsidase beta) Market Report

Report Metric Details
Report Name Fabrazyme (agalsidase beta) Market
Segment by Type
  • 5mg/vial
  • 35mg/vial
Segment by Application
  • Hospital
  • Drug store
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Fabrazyme (agalsidase beta) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Fabrazyme (agalsidase beta) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fabrazyme (agalsidase beta) sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

What are the Application segmentation covered in the Fabrazyme (agalsidase beta) Market report?

Ans: The Applications covered in the Fabrazyme (agalsidase beta) Market report are Hospital, Drug store

What are the Type segmentation covered in the Fabrazyme (agalsidase beta) Market report?

Ans: The Types covered in the Fabrazyme (agalsidase beta) Market report are 5mg/vial, 35mg/vial

Recommended Reports

Enzyme Replacement Therapies

Orphan & Rare Diseases

Neurological Disease Drugs

1 Study Coverage
1.1 Fabrazyme (agalsidase beta) Product Introduction
1.2 Market by Type
1.2.1 Global Fabrazyme (agalsidase beta) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 5mg/vial
1.2.3 35mg/vial
1.3 Market by Application
1.3.1 Global Fabrazyme (agalsidase beta) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drug store
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Fabrazyme (agalsidase beta) Sales Estimates and Forecasts 2019-2030
2.2 Global Fabrazyme (agalsidase beta) Revenue by Region
2.2.1 Global Fabrazyme (agalsidase beta) Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Fabrazyme (agalsidase beta) Revenue by Region (2019-2024)
2.2.3 Global Fabrazyme (agalsidase beta) Revenue by Region (2025-2030)
2.2.4 Global Fabrazyme (agalsidase beta) Revenue Market Share by Region (2019-2030)
2.3 Global Fabrazyme (agalsidase beta) Sales Estimates and Forecasts 2019-2030
2.4 Global Fabrazyme (agalsidase beta) Sales by Region
2.4.1 Global Fabrazyme (agalsidase beta) Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Fabrazyme (agalsidase beta) Sales by Region (2019-2024)
2.4.3 Global Fabrazyme (agalsidase beta) Sales by Region (2025-2030)
2.4.4 Global Fabrazyme (agalsidase beta) Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Fabrazyme (agalsidase beta) Sales by Manufacturers
3.1.1 Global Fabrazyme (agalsidase beta) Sales by Manufacturers (2019-2024)
3.1.2 Global Fabrazyme (agalsidase beta) Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Fabrazyme (agalsidase beta) in 2023
3.2 Global Fabrazyme (agalsidase beta) Revenue by Manufacturers
3.2.1 Global Fabrazyme (agalsidase beta) Revenue by Manufacturers (2019-2024)
3.2.2 Global Fabrazyme (agalsidase beta) Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Fabrazyme (agalsidase beta) Revenue in 2023
3.3 Global Key Players of Fabrazyme (agalsidase beta), Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Fabrazyme (agalsidase beta) Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Fabrazyme (agalsidase beta) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Fabrazyme (agalsidase beta), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Fabrazyme (agalsidase beta), Product Offered and Application
3.8 Global Key Manufacturers of Fabrazyme (agalsidase beta), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Fabrazyme (agalsidase beta) Sales by Type
4.1.1 Global Fabrazyme (agalsidase beta) Historical Sales by Type (2019-2024)
4.1.2 Global Fabrazyme (agalsidase beta) Forecasted Sales by Type (2025-2030)
4.1.3 Global Fabrazyme (agalsidase beta) Sales Market Share by Type (2019-2030)
4.2 Global Fabrazyme (agalsidase beta) Revenue by Type
4.2.1 Global Fabrazyme (agalsidase beta) Historical Revenue by Type (2019-2024)
4.2.2 Global Fabrazyme (agalsidase beta) Forecasted Revenue by Type (2025-2030)
4.2.3 Global Fabrazyme (agalsidase beta) Revenue Market Share by Type (2019-2030)
4.3 Global Fabrazyme (agalsidase beta) Price by Type
4.3.1 Global Fabrazyme (agalsidase beta) Price by Type (2019-2024)
4.3.2 Global Fabrazyme (agalsidase beta) Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Fabrazyme (agalsidase beta) Sales by Application
5.1.1 Global Fabrazyme (agalsidase beta) Historical Sales by Application (2019-2024)
5.1.2 Global Fabrazyme (agalsidase beta) Forecasted Sales by Application (2025-2030)
5.1.3 Global Fabrazyme (agalsidase beta) Sales Market Share by Application (2019-2030)
5.2 Global Fabrazyme (agalsidase beta) Revenue by Application
5.2.1 Global Fabrazyme (agalsidase beta) Historical Revenue by Application (2019-2024)
5.2.2 Global Fabrazyme (agalsidase beta) Forecasted Revenue by Application (2025-2030)
5.2.3 Global Fabrazyme (agalsidase beta) Revenue Market Share by Application (2019-2030)
5.3 Global Fabrazyme (agalsidase beta) Price by Application
5.3.1 Global Fabrazyme (agalsidase beta) Price by Application (2019-2024)
5.3.2 Global Fabrazyme (agalsidase beta) Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Fabrazyme (agalsidase beta) Market Size by Type
6.1.1 US & Canada Fabrazyme (agalsidase beta) Sales by Type (2019-2030)
6.1.2 US & Canada Fabrazyme (agalsidase beta) Revenue by Type (2019-2030)
6.2 US & Canada Fabrazyme (agalsidase beta) Market Size by Application
6.2.1 US & Canada Fabrazyme (agalsidase beta) Sales by Application (2019-2030)
6.2.2 US & Canada Fabrazyme (agalsidase beta) Revenue by Application (2019-2030)
6.3 US & Canada Fabrazyme (agalsidase beta) Market Size by Country
6.3.1 US & Canada Fabrazyme (agalsidase beta) Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Fabrazyme (agalsidase beta) Sales by Country (2019-2030)
6.3.3 US & Canada Fabrazyme (agalsidase beta) Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Fabrazyme (agalsidase beta) Market Size by Type
7.1.1 Europe Fabrazyme (agalsidase beta) Sales by Type (2019-2030)
7.1.2 Europe Fabrazyme (agalsidase beta) Revenue by Type (2019-2030)
7.2 Europe Fabrazyme (agalsidase beta) Market Size by Application
7.2.1 Europe Fabrazyme (agalsidase beta) Sales by Application (2019-2030)
7.2.2 Europe Fabrazyme (agalsidase beta) Revenue by Application (2019-2030)
7.3 Europe Fabrazyme (agalsidase beta) Market Size by Country
7.3.1 Europe Fabrazyme (agalsidase beta) Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Fabrazyme (agalsidase beta) Sales by Country (2019-2030)
7.3.3 Europe Fabrazyme (agalsidase beta) Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Fabrazyme (agalsidase beta) Market Size
8.1.1 China Fabrazyme (agalsidase beta) Sales (2019-2030)
8.1.2 China Fabrazyme (agalsidase beta) Revenue (2019-2030)
8.2 China Fabrazyme (agalsidase beta) Market Size by Application
8.2.1 China Fabrazyme (agalsidase beta) Sales by Application (2019-2030)
8.2.2 China Fabrazyme (agalsidase beta) Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Fabrazyme (agalsidase beta) Market Size by Type
9.1.1 Asia Fabrazyme (agalsidase beta) Sales by Type (2019-2030)
9.1.2 Asia Fabrazyme (agalsidase beta) Revenue by Type (2019-2030)
9.2 Asia Fabrazyme (agalsidase beta) Market Size by Application
9.2.1 Asia Fabrazyme (agalsidase beta) Sales by Application (2019-2030)
9.2.2 Asia Fabrazyme (agalsidase beta) Revenue by Application (2019-2030)
9.3 Asia Fabrazyme (agalsidase beta) Sales by Region
9.3.1 Asia Fabrazyme (agalsidase beta) Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Fabrazyme (agalsidase beta) Revenue by Region (2019-2030)
9.3.3 Asia Fabrazyme (agalsidase beta) Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Market Size by Type
10.1.1 Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Market Size by Application
10.2.1 Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Sales by Country
10.3.1 Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Genzyme Corporation
11.1.1 Genzyme Corporation Company Information
11.1.2 Genzyme Corporation Overview
11.1.3 Genzyme Corporation Fabrazyme (agalsidase beta) Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Genzyme Corporation Fabrazyme (agalsidase beta) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Genzyme Corporation Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Fabrazyme (agalsidase beta) Industry Chain Analysis
12.2 Fabrazyme (agalsidase beta) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Fabrazyme (agalsidase beta) Production Mode & Process
12.4 Fabrazyme (agalsidase beta) Sales and Marketing
12.4.1 Fabrazyme (agalsidase beta) Sales Channels
12.4.2 Fabrazyme (agalsidase beta) Distributors
12.5 Fabrazyme (agalsidase beta) Customers
13 Market Dynamics
13.1 Fabrazyme (agalsidase beta) Industry Trends
13.2 Fabrazyme (agalsidase beta) Market Drivers
13.3 Fabrazyme (agalsidase beta) Market Challenges
13.4 Fabrazyme (agalsidase beta) Market Restraints
14 Key Findings in The Global Fabrazyme (agalsidase beta) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Genzyme Corporation
List of Tables
    Table 1. Global Fabrazyme (agalsidase beta) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of 5mg/vial
    Table 3. Major Manufacturers of 35mg/vial
    Table 4. Global Fabrazyme (agalsidase beta) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Fabrazyme (agalsidase beta) Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Fabrazyme (agalsidase beta) Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Fabrazyme (agalsidase beta) Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Fabrazyme (agalsidase beta) Revenue Market Share by Region (2019-2024)
    Table 9. Global Fabrazyme (agalsidase beta) Revenue Market Share by Region (2025-2030)
    Table 10. Global Fabrazyme (agalsidase beta) Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Fabrazyme (agalsidase beta) Sales by Region (2019-2024) & (K Units)
    Table 12. Global Fabrazyme (agalsidase beta) Sales by Region (2025-2030) & (K Units)
    Table 13. Global Fabrazyme (agalsidase beta) Sales Market Share by Region (2019-2024)
    Table 14. Global Fabrazyme (agalsidase beta) Sales Market Share by Region (2025-2030)
    Table 15. Global Fabrazyme (agalsidase beta) Sales by Manufacturers (2019-2024) & (K Units)
    Table 16. Global Fabrazyme (agalsidase beta) Sales Share by Manufacturers (2019-2024)
    Table 17. Global Fabrazyme (agalsidase beta) Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Fabrazyme (agalsidase beta) Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Fabrazyme (agalsidase beta), Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Fabrazyme (agalsidase beta) Price by Manufacturers 2019-2024 (USD/Unit)
    Table 21. Global Fabrazyme (agalsidase beta) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Fabrazyme (agalsidase beta) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fabrazyme (agalsidase beta) as of 2023)
    Table 23. Global Key Manufacturers of Fabrazyme (agalsidase beta), Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Fabrazyme (agalsidase beta), Product Offered and Application
    Table 25. Global Key Manufacturers of Fabrazyme (agalsidase beta), Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Fabrazyme (agalsidase beta) Sales by Type (2019-2024) & (K Units)
    Table 28. Global Fabrazyme (agalsidase beta) Sales by Type (2025-2030) & (K Units)
    Table 29. Global Fabrazyme (agalsidase beta) Sales Share by Type (2019-2024)
    Table 30. Global Fabrazyme (agalsidase beta) Sales Share by Type (2025-2030)
    Table 31. Global Fabrazyme (agalsidase beta) Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Fabrazyme (agalsidase beta) Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Fabrazyme (agalsidase beta) Revenue Share by Type (2019-2024)
    Table 34. Global Fabrazyme (agalsidase beta) Revenue Share by Type (2025-2030)
    Table 35. Fabrazyme (agalsidase beta) Price by Type (2019-2024) & (USD/Unit)
    Table 36. Global Fabrazyme (agalsidase beta) Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 37. Global Fabrazyme (agalsidase beta) Sales by Application (2019-2024) & (K Units)
    Table 38. Global Fabrazyme (agalsidase beta) Sales by Application (2025-2030) & (K Units)
    Table 39. Global Fabrazyme (agalsidase beta) Sales Share by Application (2019-2024)
    Table 40. Global Fabrazyme (agalsidase beta) Sales Share by Application (2025-2030)
    Table 41. Global Fabrazyme (agalsidase beta) Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Fabrazyme (agalsidase beta) Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Fabrazyme (agalsidase beta) Revenue Share by Application (2019-2024)
    Table 44. Global Fabrazyme (agalsidase beta) Revenue Share by Application (2025-2030)
    Table 45. Fabrazyme (agalsidase beta) Price by Application (2019-2024) & (USD/Unit)
    Table 46. Global Fabrazyme (agalsidase beta) Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 47. US & Canada Fabrazyme (agalsidase beta) Sales by Type (2019-2024) & (K Units)
    Table 48. US & Canada Fabrazyme (agalsidase beta) Sales by Type (2025-2030) & (K Units)
    Table 49. US & Canada Fabrazyme (agalsidase beta) Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Fabrazyme (agalsidase beta) Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Fabrazyme (agalsidase beta) Sales by Application (2019-2024) & (K Units)
    Table 52. US & Canada Fabrazyme (agalsidase beta) Sales by Application (2025-2030) & (K Units)
    Table 53. US & Canada Fabrazyme (agalsidase beta) Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Fabrazyme (agalsidase beta) Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Fabrazyme (agalsidase beta) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Fabrazyme (agalsidase beta) Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Fabrazyme (agalsidase beta) Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Fabrazyme (agalsidase beta) Sales by Country (2019-2024) & (K Units)
    Table 59. US & Canada Fabrazyme (agalsidase beta) Sales by Country (2025-2030) & (K Units)
    Table 60. Europe Fabrazyme (agalsidase beta) Sales by Type (2019-2024) & (K Units)
    Table 61. Europe Fabrazyme (agalsidase beta) Sales by Type (2025-2030) & (K Units)
    Table 62. Europe Fabrazyme (agalsidase beta) Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Fabrazyme (agalsidase beta) Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Fabrazyme (agalsidase beta) Sales by Application (2019-2024) & (K Units)
    Table 65. Europe Fabrazyme (agalsidase beta) Sales by Application (2025-2030) & (K Units)
    Table 66. Europe Fabrazyme (agalsidase beta) Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Fabrazyme (agalsidase beta) Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Fabrazyme (agalsidase beta) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Fabrazyme (agalsidase beta) Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Fabrazyme (agalsidase beta) Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Fabrazyme (agalsidase beta) Sales by Country (2019-2024) & (K Units)
    Table 72. Europe Fabrazyme (agalsidase beta) Sales by Country (2025-2030) & (K Units)
    Table 73. China Fabrazyme (agalsidase beta) Sales by Type (2019-2024) & (K Units)
    Table 74. China Fabrazyme (agalsidase beta) Sales by Type (2025-2030) & (K Units)
    Table 75. China Fabrazyme (agalsidase beta) Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Fabrazyme (agalsidase beta) Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Fabrazyme (agalsidase beta) Sales by Application (2019-2024) & (K Units)
    Table 78. China Fabrazyme (agalsidase beta) Sales by Application (2025-2030) & (K Units)
    Table 79. China Fabrazyme (agalsidase beta) Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Fabrazyme (agalsidase beta) Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Fabrazyme (agalsidase beta) Sales by Type (2019-2024) & (K Units)
    Table 82. Asia Fabrazyme (agalsidase beta) Sales by Type (2025-2030) & (K Units)
    Table 83. Asia Fabrazyme (agalsidase beta) Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Fabrazyme (agalsidase beta) Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Fabrazyme (agalsidase beta) Sales by Application (2019-2024) & (K Units)
    Table 86. Asia Fabrazyme (agalsidase beta) Sales by Application (2025-2030) & (K Units)
    Table 87. Asia Fabrazyme (agalsidase beta) Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Fabrazyme (agalsidase beta) Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Fabrazyme (agalsidase beta) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Fabrazyme (agalsidase beta) Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Fabrazyme (agalsidase beta) Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Fabrazyme (agalsidase beta) Sales by Region (2019-2024) & (K Units)
    Table 93. Asia Fabrazyme (agalsidase beta) Sales by Region (2025-2030) & (K Units)
    Table 94. Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Sales by Type (2019-2024) & (K Units)
    Table 95. Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Sales by Type (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Sales by Application (2019-2024) & (K Units)
    Table 99. Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Sales by Application (2025-2030) & (K Units)
    Table 100. Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Sales by Country (2019-2024) & (K Units)
    Table 106. Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Sales by Country (2025-2030) & (K Units)
    Table 107. Genzyme Corporation Company Information
    Table 108. Genzyme Corporation Description and Major Businesses
    Table 109. Genzyme Corporation Fabrazyme (agalsidase beta) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. Genzyme Corporation Fabrazyme (agalsidase beta) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Genzyme Corporation Recent Developments
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. Fabrazyme (agalsidase beta) Distributors List
    Table 115. Fabrazyme (agalsidase beta) Customers List
    Table 116. Fabrazyme (agalsidase beta) Market Trends
    Table 117. Fabrazyme (agalsidase beta) Market Drivers
    Table 118. Fabrazyme (agalsidase beta) Market Challenges
    Table 119. Fabrazyme (agalsidase beta) Market Restraints
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
List of Figures
    Figure 1. Fabrazyme (agalsidase beta) Product Picture
    Figure 2. Global Fabrazyme (agalsidase beta) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Fabrazyme (agalsidase beta) Market Share by Type in 2023 & 2030
    Figure 4. 5mg/vial Product Picture
    Figure 5. 35mg/vial Product Picture
    Figure 6. Global Fabrazyme (agalsidase beta) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Fabrazyme (agalsidase beta) Market Share by Application in 2023 & 2030
    Figure 8. Hospital
    Figure 9. Drug store
    Figure 10. Fabrazyme (agalsidase beta) Report Years Considered
    Figure 11. Global Fabrazyme (agalsidase beta) Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Fabrazyme (agalsidase beta) Revenue 2019-2030 (US$ Million)
    Figure 13. Global Fabrazyme (agalsidase beta) Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 14. Global Fabrazyme (agalsidase beta) Revenue Market Share by Region (2019-2030)
    Figure 15. Global Fabrazyme (agalsidase beta) Sales 2019-2030 ((K Units)
    Figure 16. Global Fabrazyme (agalsidase beta) Sales Market Share by Region (2019-2030)
    Figure 17. US & Canada Fabrazyme (agalsidase beta) Sales YoY (2019-2030) & (K Units)
    Figure 18. US & Canada Fabrazyme (agalsidase beta) Revenue YoY (2019-2030) & (US$ Million)
    Figure 19. Europe Fabrazyme (agalsidase beta) Sales YoY (2019-2030) & (K Units)
    Figure 20. Europe Fabrazyme (agalsidase beta) Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. China Fabrazyme (agalsidase beta) Sales YoY (2019-2030) & (K Units)
    Figure 22. China Fabrazyme (agalsidase beta) Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Asia (excluding China) Fabrazyme (agalsidase beta) Sales YoY (2019-2030) & (K Units)
    Figure 24. Asia (excluding China) Fabrazyme (agalsidase beta) Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Sales YoY (2019-2030) & (K Units)
    Figure 26. Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. The Fabrazyme (agalsidase beta) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 28. The Top 5 and 10 Largest Manufacturers of Fabrazyme (agalsidase beta) in the World: Market Share by Fabrazyme (agalsidase beta) Revenue in 2023
    Figure 29. Global Fabrazyme (agalsidase beta) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 30. Global Fabrazyme (agalsidase beta) Sales Market Share by Type (2019-2030)
    Figure 31. Global Fabrazyme (agalsidase beta) Revenue Market Share by Type (2019-2030)
    Figure 32. Global Fabrazyme (agalsidase beta) Sales Market Share by Application (2019-2030)
    Figure 33. Global Fabrazyme (agalsidase beta) Revenue Market Share by Application (2019-2030)
    Figure 34. US & Canada Fabrazyme (agalsidase beta) Sales Market Share by Type (2019-2030)
    Figure 35. US & Canada Fabrazyme (agalsidase beta) Revenue Market Share by Type (2019-2030)
    Figure 36. US & Canada Fabrazyme (agalsidase beta) Sales Market Share by Application (2019-2030)
    Figure 37. US & Canada Fabrazyme (agalsidase beta) Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada Fabrazyme (agalsidase beta) Revenue Share by Country (2019-2030)
    Figure 39. US & Canada Fabrazyme (agalsidase beta) Sales Share by Country (2019-2030)
    Figure 40. U.S. Fabrazyme (agalsidase beta) Revenue (2019-2030) & (US$ Million)
    Figure 41. Canada Fabrazyme (agalsidase beta) Revenue (2019-2030) & (US$ Million)
    Figure 42. Europe Fabrazyme (agalsidase beta) Sales Market Share by Type (2019-2030)
    Figure 43. Europe Fabrazyme (agalsidase beta) Revenue Market Share by Type (2019-2030)
    Figure 44. Europe Fabrazyme (agalsidase beta) Sales Market Share by Application (2019-2030)
    Figure 45. Europe Fabrazyme (agalsidase beta) Revenue Market Share by Application (2019-2030)
    Figure 46. Europe Fabrazyme (agalsidase beta) Revenue Share by Country (2019-2030)
    Figure 47. Europe Fabrazyme (agalsidase beta) Sales Share by Country (2019-2030)
    Figure 48. Germany Fabrazyme (agalsidase beta) Revenue (2019-2030) & (US$ Million)
    Figure 49. France Fabrazyme (agalsidase beta) Revenue (2019-2030) & (US$ Million)
    Figure 50. U.K. Fabrazyme (agalsidase beta) Revenue (2019-2030) & (US$ Million)
    Figure 51. Italy Fabrazyme (agalsidase beta) Revenue (2019-2030) & (US$ Million)
    Figure 52. Russia Fabrazyme (agalsidase beta) Revenue (2019-2030) & (US$ Million)
    Figure 53. China Fabrazyme (agalsidase beta) Sales Market Share by Type (2019-2030)
    Figure 54. China Fabrazyme (agalsidase beta) Revenue Market Share by Type (2019-2030)
    Figure 55. China Fabrazyme (agalsidase beta) Sales Market Share by Application (2019-2030)
    Figure 56. China Fabrazyme (agalsidase beta) Revenue Market Share by Application (2019-2030)
    Figure 57. Asia Fabrazyme (agalsidase beta) Sales Market Share by Type (2019-2030)
    Figure 58. Asia Fabrazyme (agalsidase beta) Revenue Market Share by Type (2019-2030)
    Figure 59. Asia Fabrazyme (agalsidase beta) Sales Market Share by Application (2019-2030)
    Figure 60. Asia Fabrazyme (agalsidase beta) Revenue Market Share by Application (2019-2030)
    Figure 61. Asia Fabrazyme (agalsidase beta) Revenue Share by Region (2019-2030)
    Figure 62. Asia Fabrazyme (agalsidase beta) Sales Share by Region (2019-2030)
    Figure 63. Japan Fabrazyme (agalsidase beta) Revenue (2019-2030) & (US$ Million)
    Figure 64. South Korea Fabrazyme (agalsidase beta) Revenue (2019-2030) & (US$ Million)
    Figure 65. China Taiwan Fabrazyme (agalsidase beta) Revenue (2019-2030) & (US$ Million)
    Figure 66. Southeast Asia Fabrazyme (agalsidase beta) Revenue (2019-2030) & (US$ Million)
    Figure 67. India Fabrazyme (agalsidase beta) Revenue (2019-2030) & (US$ Million)
    Figure 68. Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Sales Market Share by Type (2019-2030)
    Figure 69. Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Revenue Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Sales Market Share by Application (2019-2030)
    Figure 71. Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Revenue Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Revenue Share by Country (2019-2030)
    Figure 73. Middle East, Africa and Latin America Fabrazyme (agalsidase beta) Sales Share by Country (2019-2030)
    Figure 74. Brazil Fabrazyme (agalsidase beta) Revenue (2019-2030) & (US$ Million)
    Figure 75. Mexico Fabrazyme (agalsidase beta) Revenue (2019-2030) & (US$ Million)
    Figure 76. Turkey Fabrazyme (agalsidase beta) Revenue (2019-2030) & (US$ Million)
    Figure 77. Israel Fabrazyme (agalsidase beta) Revenue (2019-2030) & (US$ Million)
    Figure 78. GCC Countries Fabrazyme (agalsidase beta) Revenue (2019-2030) & (US$ Million)
    Figure 79. Fabrazyme (agalsidase beta) Value Chain
    Figure 80. Fabrazyme (agalsidase beta) Production Process
    Figure 81. Channels of Distribution
    Figure 82. Distributors Profiles
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Fabry Disease Treatment Market Insights Forecast to 2030
Global Migalastat API Market Research Report 2024
Global α Glucosidase Inhibitors Market Research Report 2024
Global Gaucher s Disease Oral Therapy Market Research Report 2024
Gaucher s Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lysosomal Acid Lipase Deficiency Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Deslanoside Market Insights Forecast to 2030
Global Lysosomal Storage Disease Treatment Market Research Report 2024
Global Type 1 Gaucher Disease Treatment Market Research Report 2024
Global Substrate Inhibition Therapy of Gaucher Disease Market Research Report 2024
Beta galactosidase Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nateglinide Market Research Report 2024
Global Velaglucerase Alfa Market Research Report 2024
Global Recombinant Glucocerebrosidase Market Research Report 2024
Global Eliglustat API Market Research Report 2024
Global Nafamostat Mesylate Market Research Report 2024
Global Feed Galactosidase Market Insights Forecast to 2030
AmBisome Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Focal Nodular Glomerulosclerosis FSGS Treatment Medicine Market Research Report 2025
Global Migalasta Reagent Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions